Enhanced-Affinity Anti-ECM Nanobody-Cytokine Fusions and Their Applications
Exclusively Licensed
Invention type: Technology
/
Case number: #23602
Provided herein are anti-FN-EIIIB nanobodies, conjugates thereof, and methods of using the nanobodies and conjugates thereof.
Researchers
Richard Hynes
/
Emi Lutz
/
Noor Momin
/
Noor Jailkhani
/
Karl Dane Wittrup
Departments: Department of Biology, Department of Chemical Engineering
Technology Areas: Biotechnology: Synthetic Biology / Drug Discovery and Research Tools: Antibodies / Therapeutics: Proteins & Antibodies, Small Molecules
Impact Areas: Healthy Living
-
enhanced-affinity anti-ecm nanobody-cytokine fusions and their applications
United States of America | Published application -
enhanced-affinity anti-ecm nanobody-cytokine fusions and their applications
Australia | Pending -
enhanced-affinity anti-ecm nanobody-cytokine fusions and their applications
China | Published application -
enhanced-affinity anti-ecm nanobody-cytokine fusions and their applications
India | Published application -
enhanced-affinity anti-ecm nanobody-cytokine fusions and their applications
Japan | Published application -
enhanced-affinity anti-ecm nanobody-cytokine fusions and their applications
European Patent Convention | Published application
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.